Skip to main content

Invasive Fungal Infection clinical trials at UC Health
2 in progress, 1 open to eligible people

  • Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options

    open to eligible people ages 18 years and up

    A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options.

    at UC Davis UCSD

  • Registry of Patients Treated With Systemic Mold-Active Triazoles

    Sorry, in progress, not accepting new patients

    The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).

    at UC Davis UCLA

Last updated: